Strength determines confidence
Release time:
2020-08-14
Strength Determines Strength
Life is a balance beam. When you are weak, all difficulties will tilt towards you. When you are constantly strong and have skills, you will have strength and confidence to keep your life balanced.
I have participated in many symposiums organized by the company, at which I talked about the development of enterprises and personal development. The development of enterprises and personal development, the two are complementary. The development of an enterprise depends on the quality and efficiency of its products. Where does quality come from, by research and development, by production. The R & D and production front-line personnel are involved in the whole process. If individuals want to develop, they must constantly improve their professional skills, be familiar with product technology, integrate themselves into the team, and create greater value. This value, can promote the enterprise to get better development, then, this is the strength of the enterprise. As a wholly-owned subsidiary of Jianfeng Group,
Jianfeng Pharmaceutical Co., Ltd. adopted the strategic mode of "grasping both ends (products and sales) and promoting the middle ( production ) " from the beginning of acquisition, merger and equity participation to the formal registration and establishment of 1998 12 , focus on innovation, from the drug research and development link to grasp the quality. Nowadays, the direction of research and development has shifted from antidepressants, antibiotics, and cardiovascular and cerebrovascular drugs to anti-tumor preparations, Junior College drugs, and children's drugs, and has launched a number of key products, occupying a dominant position in the market. 2007 August April 31 approved the listing of penciclovir for injection. After more than 8 years, the company invested more than 1000 yuan, leading some European and American countries and becoming the exclusive new drug listed in the world. At present, the company is actively carrying out new drug research and development, the injection of deoxygenated podophyllotoxin has been approved by the State Administration of Drug Administration for clinical trials, is expected to complete clinical trials and declare production in 2021 . Deoxypodophyllotoxin as a new class of cytotoxic anti-tumor drugs, compared with similar antineoplastic drugs, has a high efficiency, broad-spectrum anti-tumor activity, the drug-resistant tumor strains and sensitive tumor strains are equally effective, while the impact on the heart, liver and bone marrow is smaller. This product has won many patents since it was developed in 2010 . If the clinical trial is successful, it can replace the similar anti-tumor drugs that have been listed in China and become the first-line drug in the market and the first product of the global patent. The emergence of such new drugs is bound to fill the gaps in the market for similar drugs and increase the company's market competitiveness.
Analyzes the current general environment of the pharmaceutical industry. In 2017 , the state vigorously implemented the medical reform policy, further implemented the "two-vote system" and "graded diagnosis and treatment", controlled the proportion of drugs in hospitals, and put pressure on product sales after implementing "standardized drug use". The implementation of bidding mechanisms in different places has also made it difficult for non-medical insurance products to enter hospitals, the survival of the non-exclusive product market is worrying. In order to better solve these problems, in addition to changing the sales model and price strategy, we should also return to the R & D and production of products, and strive to control the standard operation of raw materials, production technology and equipment. Then the quality of products and the new drugs developed will become the strength of enterprises. With this strength to impact the market, sales will have more confidence.
Strength is the power of real talent and learning. Whether at work or in life, our confidence is the most important and basic thing that comes from our own strength. Therefore, only when you become stronger can you have the courage and perseverance to impact the broader overseas market after standing firm in the local market. (Lang Minxiao)
More information
In March, the authoritative organization of the cement industry successively released two series of lists of China's top 500 building materials enterprises in 2022 and China's top 100 cement clinker production capacity in 2022. Jianfeng Group ranked among the "top 100" in the two lists ". The list of China's top 500 building materials enterprises was officially released in early March. This series of lists was selected by the China Building Materials Enterprise Management Association. Through more than 20 years of comprehensive data research on China's building materials industry, referring to international practices, the rankings are based on the company's annual operating income., Cement products, building ceramics, waterproof materials, aluminum-plastic profiles, coatings, glass, building materials equipment manufacturing and other sub-industries related to building materials. Jianfeng Group ranks 96th among the companies on the list and 27th among the cement manufacturers on the list. On March 16, the awarding ceremony of 2022 China's top 100 cement clinker production capacity list was held in Hangzhou. This series of lists is released by China Cement Network, an authoritative organization in China's cement industry. The ranking is based on the total production capacity (excluding the production capacity of other kiln types and grinding stations) of new dry clinker production lines completed and put into operation by Chinese cement enterprises in China as of December 31, 2022. The data statistics are calculated based on the design production capacity and 310 days of annual operation. Jianfeng Group ranked 53rd with an annual design capacity of 3.627 million tons. (this newspaper reporter)
2023
03-21
Company sends off retired employees
On the morning of February 22, the trade union of the group company held a simple and warm farewell party for retired employees in 2021-2022. More than 50 retired employees gathered together to discuss and exchange with Jiang Xiaomeng and other group leaders.
2023
03-04
On the first day of the new year, group leaders went to the grassroots level.
On January 29, the first day of work after the Spring Festival holiday, the leaders of the group company made a video connection to subordinate enterprises stationed abroad, and separately visited the gold enterprises to learn about the resumption of work and put forward requirements for the implementation of the work plan for the new year.
2023
02-17
Group Companies Commend 2022 Advanced
On the morning of January 18, the group company held the 2022 annual summary commendation meeting to review the work of the previous year, make arrangements for the work in 2023, sign the 2023 economic responsibility system with various professional companies and directly affiliated enterprises, and solemnly commend the 2022 advanced collectives and individuals.
2023
01-29
Jiang Xiaomeng re-elected chairman of the Municipal Federation of Industry and Commerce
On December 24, 2022, the Jinhua Federation of Industry and Commerce (General Chamber of Commerce) held the seventh member representative meeting. Jiang Xiaomeng, secretary of the party committee and chairman of the group company, was re-elected as the chairman of the Municipal Federation of Industry and Commerce at this meeting.
2023
01-12
Peak Pharmaceutical Donates Epidemic Prevention Materials
Since the optimization and adjustment of the new crown infection epidemic management policy, there has been an explosive growth of infected people in the country, and the pressure on the supply of related materials has increased sharply. Before and after New Year's Day, the company has twice organized epidemic prevention materials, through the Jinhua City Charity Federation, Jinhua City Economic and Technological Development Zone Charity Federation targeted donations, a total value of more than 200,000 yuan.
2023
01-12